时间标签：数据日期 2026-11-05 · 生成时间 2026-11-05 05:30（Asia/Shanghai）｜ 检索窗口 PubMed edat 2026/11/02 – 2026/11/06 ｜ 情报发生日期 2026-11-05
证据级别：摘要级。本条依据 PubMed 结构化摘要与元数据撰写，付费墙全文未获取、未逐节核验，本站未做任何数值推算补全。
摘要（PubMed 原文节选）
Ovarian cancer remains one of the most lethal gynecological malignancies, largely due to late diagnosis and the frequent development of resistance to platinum-based chemotherapy and taxanes. Increasing evidence implicates microRNAs as key regulators of drug response through their control of DNA damage response and repair, apoptosis, epith…
对本项目的价值
参考价值：属「衰老细胞清除 / SASP 轴」方向；细胞衰老 / senolytics / SASP栏目可用作本项目文献库与综述素材。 ｜ 价值分 1.8/5（★★☆☆☆）
全文不可及原因
无 PMCID 且 Europe PMC / OpenAlex / Unpaywall 未提供可下载 OA 全文
原文题录
- 中文题名：miRNA 调控细胞衰老：克服卵巢癌耐药的潜在策略
- 英文标题：The Role of miRNAs in Regulating Cellular Senescence: A Potential Strategy for Overcoming Drug Resistance in Ovarian Cancer.
- 期刊与标识：Frontiers in bioscience (Landmark edition) · PMID 42980015 · DOI 10.31083/FBL49279